Trials / Completed
CompletedNCT04538391
Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief
Bupivacaine Versus Meloxicam Infiltration on Post Cesarean Section Pain Relief
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- Female
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Investigation: compare the effect of local infiltration of incision site with bupivacaine and local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain relief and analgesic requirement. Condition: post cesarean sections analgesia intervention: infiltration of incision bupivacaine versus meloxicam Phase: Not applicable
Detailed description
study type: randomized clinical trial actual enrollment: 119 allocation: Random intervention model: three groups assignment masking: open lebal primary purpose: pain relief after Cesarean section actual study start: March 3, 2019 Primary Completion: March 5, 2020 actual study completion date: May 9, 2020
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | local ifiltration Bupivacaine, Meloxican and placebo | no other intervention done |
Timeline
- Start date
- 2019-03-03
- Primary completion
- 2020-03-05
- Completion
- 2020-05-09
- First posted
- 2020-09-04
- Last updated
- 2020-09-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04538391. Inclusion in this directory is not an endorsement.